Intellectus Consulting

29/07/2026

"Beyond Rhetoric: A Comparative Audit of Strategic Risk-Taking by Senior Leadership in Indian Pharma"

Executive Summary The most often question asked today when it comes to Indian pharmaceutical industry is: why does Indian pharma leadership, despite obvious talent and resources, often look conservative and reactive rather than transformative? We are tapping into a massive, heavily debated frustrati

18/07/2026

Building Power Brands Program: July 16 - 18, 2026.

Intellectus Consulting conducted a 3-day closed door program of "Building Power Brands" from July 16 - 18, 2026 in Bangalore. We had participants join in from Biocon Biologics and Zilivia Healthcare.

This is the first instance of having organized a program specifically for Bangalore-based pharma and life sciences companies.

The core fundamental modules of Insights, STP and Communication were covered extensively through methodology mix of pedagogy, case studies, and group discussions. The focus was to essentially build the strategic marketing capabilities of the participants in the three days duration.

We sincerely thank the sponsoring organizations for the support extended to our program. We also thank all participants for their wholehearted participation in the program in the course of three days.

Intellectus Consulting
Intellens - The Business Consulting Vertical of Intellectus Consulting.
Saurabh Narain
Kiran Kumar SM
Dhinesh Manoharan
Nairita Mukherjee
Anirudh Prasannan
Sayantan Chakrabarti


Intellectus Consulting

05/02/2026

📢 Kind Attention: Indian Pharma Industry Brand Managers, SPMs, GPMs, MM, GMs, Marketing Heads, BU Heads and Senior Leadership.

🌟 A Fireside Conversation: "Creating Right Pharma Brand Names & Protecting IP-Trademarks".

👉 Intellectus Consulting is pleased to host the above fireside conversation with two eminent industry leaders, Sankar Dass, Operating Partner at Jashvik Capital and Bharath M. S., Founder & CEO of leading law firm, KRIA Law based out of Chennai on Friday, February 20, 2026 from 5:00 to 6:30 pm.

👉 Registration for this event is free. No registration fee needs to be paid.

🔷 Background:

🔥 Why Pharma Brand Naming Is Uniquely High-Risk

👉 Pharma brand names sit at the intersection of patient safety, regulation, and commercial value. A weak or risky name doesn’t just dilute brand equity— it can trigger regulatory rejection, litigation, forced rebranding, or patient harm.

👉 Key risk multipliers in pharma:

🔶 Sound-alike / look-alike (LASA) medication errors
🔶 Dense trademark landscape (esp. India generics)
🔶 Multi-jurisdictional launches
🔶 Long product life cycles → IP mistakes compound over decades

✅ Trademarks are IP Assets

👉 A well-protected and defensible brand name trademark shields the hard-earned brand identity, recall and visibility from doctors and patients. Fool-proof legal protection of the brand name trademark is an absolute must. Distinctiveness is the best defensible strategy for IP protection.

👉 Both these important topics will be discussed in depth during our fireside conversation with the experts.

👉 The event flyer is attached herewith this announcement and the Google Form link for the event registration is provided at the bottom. The event agenda is provided in the flyer itself.

👉 Those who wish to attend this event need to first register. Registrations are now open and close on Wednesday, February 18, 2026 by 8:00 pm.

🌟 Important Information:

1. Registration for this event is free. No payment is required.
2. Prior registration for the program is compulsory.
3. Registrations are open. We are accepting registrations at this point of time on first-come basis.

👉 A Zoom meeting link will be sent to all registered participants two days prior to the program.

👉 Registration Google Form Link:

https://lnkd.in/g9s9q_wc

Intellectus Consulting
Intellens - The Business Consulting Vertical of Intellectus Consulting.

This link will take you to a page that’s not on LinkedIn